Vistusertib improves pulmonary inflammation and fibrosis by modulating inflammatory/oxidative stress mediators via suppressing the mTOR signalling
Taslim B. Shaikh, Yogesh Chandra, Sai Balaji Andugulapati, Ramakrishna Sistla
Topics & Concepts
InflammationOxidative stressFibrosisMedicineSignallingPulmonary fibrosisPI3K/AKT/mTOR pathwayImmunologySignalling pathwaysAllergySignal transductionPharmacologyInternal medicineChemistryReceptorBiologyCell biologyBiochemistryInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Treatments and MutationsChronic Obstructive Pulmonary Disease (COPD) Research